# Impact BioMedical Inc. (IBO)

Source: https://www.quantisnow.com/company/IBO
Generated: 2026-11-13T16:41:02.100Z

- Ticker: IBO
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2024
- SEC CIK: 0001834105

## Latest IBO news and filings

- 2026-11-09 21:50 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-impact-biomedical-inc-6781870)
- 2026-11-05 22:56 UTC [SEC Form 4] [Chief Operating Officer Suseck Mark gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-suseck-mark-gave-a-grant-of-4170-6777529)
- 2026-11-05 22:55 UTC [SEC Form 4] [Director Zimmerman Christian Thomas gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)](https://www.quantisnow.com/insight/director-zimmerman-christian-thomas-gave-a-grant-of-4170-shares-6777528)
- 2026-11-05 22:54 UTC [SEC Form 4] [Director Hibbert Castel Berisford gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hibbert-castel-berisford-gave-a-grant-of-4170-shares-6777527)
- 2026-11-05 22:53 UTC [SEC Form 4] [Director Sims Melissa Kaye gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)](https://www.quantisnow.com/insight/director-sims-melissa-kaye-gave-a-grant-of-4170-shares-6777526)
- 2026-11-05 22:51 UTC [SEC Form 4] [Director Keene David K gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)](https://www.quantisnow.com/insight/director-keene-david-k-gave-a-grant-of-4170-shares-6777525)
- 2026-11-05 22:50 UTC [SEC Form 4] [Director Brownell Elise gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)](https://www.quantisnow.com/insight/director-brownell-elise-gave-a-grant-of-4170-shares-decreasing-6777524)
- 2026-11-05 22:49 UTC [SEC Form 4] [Director Chan Heng Fai Ambrose gave a grant of 4,170 shares, decreasing direct ownership by 11% to 32,112 units (SEC Form 4)](https://www.quantisnow.com/insight/director-chan-heng-fai-ambrose-gave-a-grant-of-4170-6777522)
- 2026-11-05 22:48 UTC [SEC Form 4] [Director Grady Jason gave a grant of 4,170 shares, decreasing direct ownership by 13% to 28,164 units (SEC Form 4)](https://www.quantisnow.com/insight/director-grady-jason-gave-a-grant-of-4170-shares-decreasing-6777518)
- 2026-11-05 22:46 UTC [SEC Form 4] [Chief Financial Officer Macko Todd D gave a grant of 4,170 shares, decreasing direct ownership by 20% to 16,462 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-macko-todd-d-gave-a-grant-of-6777512)
- 2026-11-03 14:15 UTC [SEC Form 8-K] [Impact BioMedical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/impact-biomedical-inc-filed-sec-form-8-k-regulation-fd-disclosure-6768907)
- 2026-11-03 04:33 UTC [Market Insight] [DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination](https://www.quantisnow.com/insight/dss-inc-announces-sec-declaration-of-effectiveness-of-form-f-4-6768080)
- 2026-11-03 04:25 UTC [Market Insight] [Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination](https://www.quantisnow.com/insight/impact-biomedical-inc-and-zoar-limited-announce-sec-declaration-of-6768079)
- 2026-10-26 22:12 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-impact-biomedical-inc-6758211)
- 2026-10-09 20:58 UTC [SEC Form 8-K] [SEC Form 8-K filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-impact-biomedical-inc-6743138)
- 2026-09-24 23:37 UTC [SEC Form 4] [Large owner Dss, Inc. sold $1,686 worth of shares (906 units at $1.86), decreasing direct ownership by 0.15% to 589,518 units (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-dss-inc-sold-1686-worth-of-shares-906-6725841)
- 2026-09-16 13:25 UTC [DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited](https://www.quantisnow.com/insight/dss-inc-announces-form-f-4-filing-in-connection-with-impact-6717158)
- 2026-09-16 13:20 UTC [Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)](https://www.quantisnow.com/insight/impact-biomedical-inc-announces-filing-of-form-f-4-registration-statement-6717154)
- 2026-09-14 23:43 UTC [SEC Form 8-K] [Impact BioMedical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/impact-biomedical-inc-filed-sec-form-8-k-regulation-fd-disclosure-6715214)
- 2026-09-15 01:26 UTC [CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)](https://www.quantisnow.com/insight/corrected-impact-biomedical-inc-nyse-ibo-announces-1-for-1262-6715165)
- 2026-09-11 20:05 UTC [Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)](https://www.quantisnow.com/insight/impact-biomedical-inc-nyse-american-ibo-announces-1-for-1262-6712897)
- 2026-08-07 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-impact-biomedical-inc-6671865)
- 2026-05-12 20:43 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-impact-biomedical-inc-6548627)
- 2026-04-29 22:08 UTC [SEC Form 144] [SEC Form 144 filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-impact-biomedical-inc-6522079)
- 2026-04-22 20:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-impact-biomedical-inc-6510778)
- 2026-04-06 20:30 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-impact-biomedical-inc-6489539)
- 2026-04-03 17:52 UTC [Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans](https://www.quantisnow.com/insight/impact-biomedical-inc-reports-going-concern-audit-opinion-in-2025-6487109)
- 2026-03-31 01:06 UTC [SEC Form 4] [SEC Form 4 filed by Macko Todd D](https://www.quantisnow.com/insight/sec-form-4-filed-by-macko-todd-d-6477445)
- 2026-03-25 23:55 UTC [SEC Form 4] [SEC Form 4 filed by Grady Jason](https://www.quantisnow.com/insight/sec-form-4-filed-by-grady-jason-6469583)
- 2026-03-11 21:31 UTC [SEC Form 10-K] [SEC Form 10-K filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-impact-biomedical-inc-6442750)
- 2026-03-04 21:52 UTC [SEC Form 8-K] [Impact BioMedical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/impact-biomedical-inc-filed-sec-form-8-k-entry-into-a-6430049)
- 2026-01-06 22:25 UTC [SEC Form 4] [Large owner Dss, Inc. sold $88,006 worth of shares (161,000 units at $0.55), decreasing direct ownership by 23% to 545,024 units (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-dss-inc-sold-88006-worth-of-shares-161000-6339303)
- 2025-12-30 21:30 UTC [SEC Form DEF 14C filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-def-14c-filed-by-impact-biomedical-inc-6330061)
- 2025-12-11 22:11 UTC [SEC Form PRE 14C filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-pre-14c-filed-by-impact-biomedical-inc-6312878)
- 2025-11-07 21:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-impact-biomedical-inc-6268528)
- 2025-11-06 21:07 UTC [SEC Form 8-K] [Impact BioMedical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/impact-biomedical-inc-filed-sec-form-8-k-submission-of-matters-6265497)
- 2025-10-27 20:05 UTC [SEC Form 8-K] [Impact BioMedical Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/impact-biomedical-inc-filed-sec-form-8-k-other-events-6245998)
- 2025-09-22 20:40 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-impact-biomedical-inc-6208257)
- 2025-09-09 21:03 UTC [SEC Form DEF 14C filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-def-14c-filed-by-impact-biomedical-inc-6195404)
- 2025-08-26 13:14 UTC [SEC Form PRE 14C filed by Impact BioMedical Inc.](https://www.quantisnow.com/insight/sec-form-pre-14c-filed-by-impact-biomedical-inc-6178810)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IBO
- Earnings history: https://www.quantisnow.com/earnings/IBO
- Dividend history: https://www.quantisnow.com/dividends/IBO
- Insider transactions: https://www.quantisnow.com/insiders/IBO
- Options chain: https://www.quantisnow.com/options/IBO
- SEC 8-K filings only: https://www.quantisnow.com/company/IBO/8-k
- RSS and alerts for IBO: https://www.quantisnow.com/docs/rss-feeds.md